TYK Medicines, Inc. Class H ( (HK:2410) ) has provided an announcement.
TYK Medicines, Inc announced its annual results for the year ended December 31, 2024, revealing a total comprehensive loss of RMB 387,928,000, a slight increase from the previous year. The company also announced the resignation of a non-executive director and proposed amendments to its Articles of Association, signaling potential strategic shifts.
More about TYK Medicines, Inc. Class H
TYK Medicines, Inc is a joint stock company incorporated in the People’s Republic of China, operating within the pharmaceutical industry. The company focuses on research and development, as indicated by its substantial investment in R&D costs.
YTD Price Performance: -30.01%
Average Trading Volume: 588,374
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$12.09B
See more data about 2410 stock on TipRanks’ Stock Analysis page.